Bionovo Describes a New Class of Therapeutic Compounds
 

Bionovo, Inc. (NASDAQ:BNVI) announced today the publication of a groundbreaking paper in the journal Molecular and Cellular Endocrinology covering the isolation, identification and description of a pure chemical compound, liquiritigenin, which represents a new class of therapeutic compounds showing promise for the safe treatment of menopausal symptoms.

More...